RATIONALE: Altered pulmonary hemodynamics and fluid flow-induced high shear stress (HSS) are characteristic hallmarks in the pathogenesis of pulmonary arterial hypertension (PAH). However, the contribution of HSS to cellular and vascular alterations in PAH is unclear. OBJECTIVES: We hypothesize that failing shear adaptation is an essential part of the endothelial dysfunction in all forms of PAH and tested whether microvascular endothelial cells (MVECs) or pulmonary arterial endothelial cells (PAECs) from lungs of patients with PAH adapt to HSS and if the shear defect partakes in vascular remodeling in vivo. METHODS: PAH MVEC (n = 7) and PAH PAEC (n = 3) morphology, function, protein, and gene expressions were compared with control MVEC (n = 8) under static culture conditions and after 24, 72, and 120 hours of HSS. MEASUREMENTS AND MAIN RESULTS: PAH MVEC showed a significantly delayed morphological shear adaptation (P = 0.03) and evidence of cell injury at sites of nonuniform shear profiles that are critical loci for vascular remodeling in PAH. In clear contrast, PAEC isolated from the same PAH lungs showed no impairments. PAH MVEC gene expression and transcriptional shear activation were not altered but showed significant decreased protein levels (P = 0.02) and disturbed interendothelial localization of the shear sensor platelet endothelial cell adhesion molecule-1 (PECAM-1). The decreased PECAM-1 levels were caused by caspase-mediated cytoplasmic cleavage but not increased cell apoptosis. Caspase blockade stabilized PECAM-1 levels, restored endothelial shear responsiveness in vitro, and attenuated occlusive vascular remodeling in chronically hypoxic Sugen5416-treated rats modeling severe PAH. CONCLUSIONS: Delayed shear adaptation, which promotes shear-induced endothelial injury, is a newly identified dysfunction specific to the microvascular endothelium in PAH. The shear response is normalized on stabilization of PECAM-1, which reverses intimal remodeling in vivo.
RATIONALE: Altered pulmonary hemodynamics and fluid flow-induced high shear stress (HSS) are characteristic hallmarks in the pathogenesis of pulmonary arterial hypertension (PAH). However, the contribution of HSS to cellular and vascular alterations in PAH is unclear. OBJECTIVES: We hypothesize that failing shear adaptation is an essential part of the endothelial dysfunction in all forms of PAH and tested whether microvascular endothelial cells (MVECs) or pulmonary arterial endothelial cells (PAECs) from lungs of patients with PAH adapt to HSS and if the shear defect partakes in vascular remodeling in vivo. METHODS: PAH MVEC (n = 7) and PAH PAEC (n = 3) morphology, function, protein, and gene expressions were compared with control MVEC (n = 8) under static culture conditions and after 24, 72, and 120 hours of HSS. MEASUREMENTS AND MAIN RESULTS: PAH MVEC showed a significantly delayed morphological shear adaptation (P = 0.03) and evidence of cell injury at sites of nonuniform shear profiles that are critical loci for vascular remodeling in PAH. In clear contrast, PAEC isolated from the same PAH lungs showed no impairments. PAH MVEC gene expression and transcriptional shear activation were not altered but showed significant decreased protein levels (P = 0.02) and disturbed interendothelial localization of the shear sensor platelet endothelial cell adhesion molecule-1 (PECAM-1). The decreased PECAM-1 levels were caused by caspase-mediated cytoplasmic cleavage but not increased cell apoptosis. Caspase blockade stabilized PECAM-1 levels, restored endothelial shear responsiveness in vitro, and attenuated occlusive vascular remodeling in chronically hypoxic Sugen5416-treated rats modeling severe PAH. CONCLUSIONS: Delayed shear adaptation, which promotes shear-induced endothelial injury, is a newly identified dysfunction specific to the microvascular endothelium in PAH. The shear response is normalized on stabilization of PECAM-1, which reverses intimal remodeling in vivo.
Authors: Christophe Guignabert; Ly Tu; Morane Le Hiress; Nicolas Ricard; Caroline Sattler; Andrei Seferian; Alice Huertas; Marc Humbert; David Montani Journal: Eur Respir Rev Date: 2013-12
Authors: Sven Flemming; Natalie Burkard; Melanie Renschler; Franziska Vielmuth; Michael Meir; Martin Alexander Schick; Christian Wunder; Christoph-Thomas Germer; Volker Spindler; Jens Waschke; Nicolas Schlegel Journal: Cardiovasc Res Date: 2015-05-14 Impact factor: 10.787
Authors: Gerald Simonneau; Michael A Gatzoulis; Ian Adatia; David Celermajer; Chris Denton; Ardeschir Ghofrani; Miguel Angel Gomez Sanchez; R Krishna Kumar; Michael Landzberg; Roberto F Machado; Horst Olschewski; Ivan M Robbins; Rogiero Souza Journal: J Am Coll Cardiol Date: 2013-12-24 Impact factor: 24.094
Authors: Michiel Alexander de Raaf; Ingrid Schalij; Jose Gomez-Arroyo; Nina Rol; Chris Happé; Frances S de Man; Anton Vonk-Noordegraaf; Nico Westerhof; Norbert F Voelkel; Harm Jan Bogaard Journal: Eur Respir J Date: 2014-05-02 Impact factor: 16.671
Authors: Farnaz R Bakhshi; Mao Mao; Ayesha N Shajahan; Tobias Piegeler; Zhenlong Chen; Olga Chernaya; Tiffany Sharma; W Mark Elliott; Robert Szulcek; Harm Jan Bogaard; Suzy Comhair; Serpil Erzurum; Geerten P van Nieuw Amerongen; Marcelo G Bonini; Richard D Minshall Journal: Pulm Circ Date: 2013-12 Impact factor: 3.017
Authors: Paul J Pockros; Eugene R Schiff; Mitchell L Shiffman; John G McHutchison; Robert G Gish; Nezam H Afdhal; Manana Makhviladze; Mira Huyghe; David Hecht; Tilman Oltersdorf; David A Shapiro Journal: Hepatology Date: 2007-08 Impact factor: 17.425
Authors: Mark R Nicolls; Shiro Mizuno; Laima Taraseviciene-Stewart; Laszlo Farkas; Jennnifer I Drake; Aysar Al Husseini; Jose G Gomez-Arroyo; Norbert F Voelkel; Herman J Bogaard Journal: Pulm Circ Date: 2012-10 Impact factor: 3.017
Authors: Evgeny A Zemskov; Qing Lu; Wojciech Ornatowski; Christina N Klinger; Ankit A Desai; Emin Maltepe; Jason X-J Yuan; Ting Wang; Jeffrey R Fineman; Stephen M Black Journal: Antioxid Redox Signal Date: 2019-03-19 Impact factor: 8.401
Authors: Daniela Farkas; A A Roger Thompson; Aneel R Bhagwani; Schuyler Hultman; Hyun Ji; Naveen Kotha; Grant Farr; Nadine D Arnold; Adam Braithwaite; Helen Casbolt; Jennifer E Cole; Ian Sabroe; Claudia Monaco; Carlyne D Cool; Elena A Goncharova; Allan Lawrie; Laszlo Farkas Journal: Am J Respir Crit Care Med Date: 2019-01-15 Impact factor: 21.405
Authors: Michal Schäfer; D Dunbar Ivy; Steven H Abman; Alex J Barker; Lorna P Browne; Brian Fonseca; Vitaly Kheyfets; Kendall S Hunter; Uyen Truong Journal: Circ Cardiovasc Imaging Date: 2017-02 Impact factor: 7.792
Authors: Diederik E van der Feen; Guido P L Bossers; Quint A J Hagdorn; Jan-Renier Moonen; Kondababu Kurakula; Robert Szulcek; James Chappell; Francesco Vallania; Michele Donato; Klaas Kok; Jaskaren S Kohli; Arjen H Petersen; Tom van Leusden; Marco Demaria; Marie-José T H Goumans; Rudolf A De Boer; Purvesh Khatri; Marlene Rabinovitch; Rolf M F Berger; Beatrijs Bartelds Journal: Sci Transl Med Date: 2020-07-29 Impact factor: 17.956
Authors: Richard M Friesen; Michal Schäfer; D Dunbar Ivy; Steven H Abman; Kurt Stenmark; Lorna P Browne; Alex J Barker; Kendall S Hunter; Uyen Truong Journal: Eur Heart J Cardiovasc Imaging Date: 2019-02-01 Impact factor: 6.875
Authors: Sébastien Bonnet; Steeve Provencher; Christophe Guignabert; Frédéric Perros; Olivier Boucherat; Ralph Theo Schermuly; Paul M Hassoun; Marlene Rabinovitch; Mark R Nicolls; Marc Humbert Journal: Am J Respir Crit Care Med Date: 2017-03-01 Impact factor: 21.405
Authors: Evan L Brittain; Thennapan Thennapan; Bradley A Maron; Stephen Y Chan; Eric D Austin; Edda Spiekerkoetter; Harm J Bogaard; Christophe Guignabert; Roxane Paulin; Roberto F Machado; Paul B Yu Journal: Am J Respir Crit Care Med Date: 2018-07-01 Impact factor: 21.405
Authors: Mary Beth Brown; Evandro Neves; Gary Long; Jeremy Graber; Brett Gladish; Andrew Wiseman; Matthew Owens; Amanda J Fisher; Robert G Presson; Irina Petrache; Jeffrey Kline; Tim Lahm Journal: Am J Physiol Regul Integr Comp Physiol Date: 2016-10-26 Impact factor: 3.619